ACV meeting statement, Meeting 6, 7 February 2018

Section A: Submissions for registration

No item was on the agenda regarding a submission for registration.

Section B: Safety

No item was on the agenda regarding safety or pharmacovigilance issues.

Section C: Immunisation Programs

Continuing from previous meetings, the committee was asked to provide further advice on pathways for notification and investigation of serious adverse events following immunisation.

Further information

For further information on the ACV, please visit Advisory Committee on Vaccines or contact the ACV by email ACV@health.gov.au.